Technology | Radiation Therapy | July 26, 2018

New RayCare and RayStation Releases on Show at AAPM

In addition to latest releases of treatment planning system and oncology information system, RaySearch will arrange tours of the Provision Cares Proton Therapy Center in Nashville

July 26, 2018 — RaySearch will exhibit its latest advances in radiation therapy treatment planning at the 60th American Association of Physicists in Medicine (AAPM) Annual Meeting, July 29-Aug. 2 in Nashville. The company will demonstrate RayCare 2A, the latest release of its oncology information system (OIS) and RayStation 8A, the new release of the company’s treatment planning system. The latest developments in machine learning technology and online adaptive therapy will also be on show.

The new RayStation 8A release brings a broad range of advances, including full planning capabilities for the TomoTherapy and Radixact Systems from Accuray. RayStation now supports the TomoDirect delivery mode in addition to TomoHelical. Other developments in RayStation 8A include support for TomoTherapy in Plan Explorer, improvements for proton and carbon ion therapy, and further integration with RayCare OIS. All TomoTherapy and Radixact users now have access to advanced RayStation features, including multi-criteria optimization (MCO), adaptive planning and Plan Explorer.

Improvements for proton and carbon ion therapy include:

  • Automatic selection of range shifter for pencil beam scanning (PBS) machines;
  • DICOM export of magnets in the lateral spreading device sequence for all ion treatment machines; and
  • Ion beam commissioning tools have also been refined for easier use, and carbon ion treatment machines are now supported in RayStation’s physics module.

New features and a range of general system enhancements from the newly released RayCare 2A will be demonstrated. The system now incorporates RayPACS (picture archiving communication system) that makes it fast and easy to retrieve and share images. This managed PACS system makes it possible to tag images for efficient workflow automation. RayPACS can be used within RayCare or as a standalone PACS.

Other new features include task-based and rule-based scheduling, including calendar views and schedules for all clinic resources, and charge capture, a tool for automatically capturing and managing billable codes from tasks performed in the workflow.

During the AAPM conference, Provision Healthcare and RaySearch will together arrange an exclusive tour at the Provision Cares Proton Therapy Center in Nashville. The center is equipped with the latest technology within proton therapy, using the ProNova SC360 Proton system, RayCare and RayStation for all the treatment planning, enabling an integrated oncology approach and a seamless workflow experience.

The tour will give insights in the vision for the new center, as well as how Provision partnered with RaySearch in the development of RayCare.

On Sunday, July 29, RaySearch will hold an evening symposium focusing on advancing cancer care through software innovation. Speakers at the symposium will include Tom Purdie, Ph.D., medical physicist, Princess Margaret Cancer Centre, Toronto, Canada. The symposium will take place at the Hermitage Hotel, 231 6th Ave N, Nashville.

For more information: www.raysearchlabs.com

 

Related Content

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to ResearchAndMarkets.com's offering. The prostate cancer nuclear medicine diagnostics market in the US was valued at $194.47M in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach $431.76M by 2027.

Getty Images

News | Prostate Cancer | January 13, 2021
January 13, 2021 — The ...
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

News | Prostate Cancer | January 11, 2021
January 11, 2021 — A study
Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions, announced that it has acquired Sun Nuclear Corporation. Sun Nuclear is the global leader in radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers around the world.
News | Quality Assurance (QA) | January 08, 2021
January 8, 2021 — Mirion Technologies, Inc., a global provider of
RAD Technology Medical Systems (RAD) announced it is expanding its portfolio of patented modular healthcare solutions in 2021 with the introduction of a compact shielding facility designed to accommodate the latest models of low energy, self-shielded linear accelerators (linacs) that are now available worldwide. 

Image courtesy of Siemens Healthineers

News | Linear Accelerators | January 04, 2021
January 4, 2021 — RAD Technology Medical Systems (RAD) ann
RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.
News | Brachytherapy Systems | December 29, 2020
December 29, 2020 — RaySearch Laboratories AB has launched the latest release of its widely adopted treatment plannin
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.

Image courtesy of Zeiss

News | Radiation Therapy | December 21, 2020
December 21, 2020 — According to recent studies, an increase in the...